【Medigen Biotechnology】April 2026 Revenue: 0.02 Billion (Down 65.5% YoY)
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Medigen Biotechnology (6794) reported April 2026 revenue of 18.94 million yuan, a significant decrease of 65.5% year-on-year. This indicates a challenging period for the company in the biotech and medical sector.